Corvus Historical Cash Flow
| CRVS Stock | USD 5.29 0.21 4.13% |
Analysis of Corvus Pharmaceuticals cash flow over time is an excellent tool to project Corvus Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Investments of 16.9 M or Other Cashflows From Financing Activities of 20.5 K as it is a great indicator of Corvus Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Corvus Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Corvus Pharmaceuticals is a good buy for the upcoming year.
Corvus |
About Corvus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Corvus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Corvus's non-liquid assets can be easily converted into cash.
Corvus Pharmaceuticals Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Corvus Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Corvus Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Corvus Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Corvus Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corvus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Corvus Stock please use our How to Invest in Corvus Pharmaceuticals guide.At this time, Corvus Pharmaceuticals' Change To Account Receivables is comparatively stable compared to the past year.
Corvus Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Corvus Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Corvus Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 44.8M | 21.6M | (23.3M) | 14.0M | 16.1M | 16.9M | |
| Change In Cash | 11.3M | 47.0M | (50.3M) | (539K) | (485.1K) | (460.8K) | |
| Free Cash Flow | (34.9M) | (36.7M) | (27.3M) | (24.0M) | (21.6M) | (22.7M) | |
| Change In Working Capital | 1.9M | (3.2M) | 1.4M | (3.6M) | (3.2M) | (3.1M) | |
| Total Cashflows From Investing Activities | 3.3M | 44.8M | 21.6M | (23.3M) | (26.8M) | (28.1M) | |
| Other Cashflows From Financing Activities | 88K | 1.2M | (23.3M) | 24K | 21.6K | 20.5K | |
| Depreciation | 632K | 460K | 367K | 151K | 173.7K | 165.0K | |
| Other Non Cash Items | (37.1M) | 5.1M | 9.8M | 4.4M | 4.0M | 4.1M | |
| Capital Expenditures | 76K | 5K | 269K | 34K | 30.6K | 29.1K | |
| Total Cash From Operating Activities | (34.8M) | (36.7M) | (27.0M) | (23.9M) | (21.5M) | (22.6M) | |
| Change To Operating Activities | 1.5M | 890K | (827K) | 1.1M | 973.8K | 638.6K | |
| Net Income | (6.0M) | (43.2M) | (41.3M) | (27.0M) | (24.3M) | (25.5M) | |
| Total Cash From Financing Activities | 1.3M | 62.2M | 18K | 7.9M | 7.1M | 6.7M | |
| End Period Cash Flow | 16.5M | 63.5M | 13.2M | 12.6M | 14.5M | 24.0M | |
| Change To Netincome | 7.1M | 7.3M | (31.3M) | 9.3M | 8.4M | 8.8M | |
| Change To Liabilities | 2.5M | 1.0M | (1.9M) | 411K | 369.9K | 300.3K | |
| Stock Based Compensation | 5.7M | 4.2M | 2.7M | 2.1M | 1.9M | 3.5M | |
| Begin Period Cash Flow | 5.2M | 16.5M | 63.5M | 13.2M | 15.1M | 25.0M | |
| Other Cashflows From Investing Activities | 3.3M | 44.8K | 21.6K | (23.0K) | (26.5K) | (27.8K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corvus Stock Analysis
When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.